{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:59:30Z","timestamp":1787061570273,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["391243"],"award-info":[{"award-number":["391243"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016615","name":"Curing Kids Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008221","name":"Cure Starts Now Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10014-024-00493-w","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T09:27:41Z","timestamp":1727170061000},"page":"117-131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Combination treatment with histone deacetylase and carbonic anhydrase 9 inhibitors shows therapeutic potential in experimental diffuse intrinsic pontine glioma"],"prefix":"10.1007","volume":"41","author":[{"given":"Naohide","family":"Fujita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bondoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Simoes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joji","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Taccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Luck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilakshan","family":"Srikanthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Siddaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrin","family":"Sabha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Krumholtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihide","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoukat","family":"Dedhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0851-7330","authenticated-orcid":false,"given":"James","family":"Rutka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,24]]},"reference":[{"issue":"7\u20138","key":"493_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.cancergen.2015.04.008","volume":"208","author":"E Panditharatna","year":"2015","unstructured":"Panditharatna E, Yaeger K, Kilburn LB et al (2015) Clinicopathology of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape. Cancer Genet 208(7\u20138):367\u2013373","journal-title":"Cancer Genet"},{"issue":"1","key":"493_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11060-017-2514-9","volume":"134","author":"SEM Veldhuijzen van Zanten","year":"2017","unstructured":"Veldhuijzen van Zanten SEM, Lane A, Heymans MW et al (2017) External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry. J Neurooncol 134(1):231\u2013240","journal-title":"J Neurooncol"},{"issue":"5","key":"493_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s40272-013-0033-5","volume":"15","author":"R Kebudi","year":"2013","unstructured":"Kebudi R, Cakir FB (2013) Management of diffuse pontine gliomas in children: recent developments. Paediatr Drugs 15(5):351\u2013362","journal-title":"Paediatr Drugs"},{"issue":"2","key":"493_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrc2981","volume":"11","author":"RA Cairns","year":"2011","unstructured":"Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11(2):85\u201395","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"493_CR5","doi-asserted-by":"publisher","first-page":"e22445","DOI":"10.1371\/journal.pone.0022445","volume":"6","author":"A Riemann","year":"2011","unstructured":"Riemann A, Schneider B, Ihling A et al (2011) Acidic environment leads to ROS-induced MAPK signaling in cancer cells. PLoS ONE 6(7):e22445","journal-title":"PLoS ONE"},{"key":"493_CR6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fonc.2016.00069","volume":"6","author":"SJ van Kuijk","year":"2016","unstructured":"van Kuijk SJ, Yaromina A, Houben R et al (2016) Prognostic significance of carbonic anhydrase IX expression in cancer patients: a meta-analysis. Front Oncol 6:69","journal-title":"Front Oncol"},{"issue":"2","key":"493_CR7","doi-asserted-by":"publisher","first-page":"C738","DOI":"10.1152\/ajpcell.00157.2007","volume":"293","author":"PE Morgan","year":"2007","unstructured":"Morgan PE, Pastorekova S, Stuart-Tilley AK et al (2007) Interactions of transmembrane carbonic anhydrase, CAIX, with bicarbonate transporters. Am J Physiol Cell Physiol 293(2):C738\u2013C748","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"493_CR8","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3390\/molecules23051045","volume":"23","author":"S Singh","year":"2018","unstructured":"Singh S, Lomelino CL, Mboge MY et al (2018) Cancer drug development of carbonic anhydrase inhibitors beyond the active site. Molecules 23(5):1045","journal-title":"Molecules"},{"issue":"9","key":"493_CR9","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","volume":"71","author":"Y Lou","year":"2011","unstructured":"Lou Y, McDonald PC, Oloumi A et al (2011) Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 71(9):3364\u20133376","journal-title":"Cancer Res"},{"issue":"12","key":"493_CR10","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/sj.bjc.6605412","volume":"101","author":"DA Reardon","year":"2009","unstructured":"Reardon DA, Desjardins A, Vredenburgh JJ et al (2009) Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study. Br J Cancer 101(12):1986\u20131994","journal-title":"Br J Cancer"},{"issue":"10","key":"493_CR11","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/13543776.2018.1508453","volume":"28","author":"A Nocentini","year":"2018","unstructured":"Nocentini A, Supuran CT (2018) Carbonic anhydrase inhibitors as antitumor\/antimetastatic agents: a patent review (2008\u20132018). Expert Opin Ther Pat 28(10):729\u2013740","journal-title":"Expert Opin Ther Pat"},{"issue":"4","key":"493_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1215\/S1152851705000025","volume":"7","author":"MA Proescholdt","year":"2005","unstructured":"Proescholdt MA, Mayer C, Kubitza M et al (2005) Expression of hypoxia-inducible carbonic anhydrases in brain tumors. Neuro Oncol 7(4):465\u2013475","journal-title":"Neuro Oncol"},{"issue":"24","key":"493_CR13","doi-asserted-by":"publisher","first-page":"e92928","DOI":"10.1172\/jci.insight.92928","volume":"2","author":"NH Boyd","year":"2017","unstructured":"Boyd NH, Walker K, Fried J et al (2017) Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo. JCI Insight 2(24):e92928","journal-title":"JCI Insight"},{"issue":"6","key":"493_CR14","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00401-015-1478-0","volume":"130","author":"D Castel","year":"2015","unstructured":"Castel D, Philippe C, Calmon R et al (2015) Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 130(6):815\u2013827","journal-title":"Acta Neuropathol"},{"issue":"5","key":"493_CR15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00018-017-2714-7","volume":"75","author":"MH Meel","year":"2018","unstructured":"Meel MH, Schaper SA, Kaspers GJL et al (2018) Signaling pathways and mesenchymal transition in pediatric high-grade glioma. Cell Mol Life Sci 75(5):871\u2013887","journal-title":"Cell Mol Life Sci"},{"issue":"14","key":"493_CR16","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1158\/0008-5472.CAN-17-3691","volume":"78","author":"S Pal","year":"2018","unstructured":"Pal S, Kozono D, Yang X et al (2018) Dual HDAC and PI3K inhibition abrogates NFkappaB- and FOXM1-mediated DNA damage response to radiosensitize pediatric high-grade gliomas. Cancer Res 78(14):4007\u20134021","journal-title":"Cancer Res"},{"issue":"1","key":"493_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/14756366.2019.1706090","volume":"35","author":"J Ruzzolini","year":"2020","unstructured":"Ruzzolini J, Laurenzana A, Andreucci E et al (2020) A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer. J Enzyme Inhib Med Chem 35(1):391\u2013397","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"493_CR18","doi-asserted-by":"publisher","first-page":"6216","DOI":"10.1038\/s41467-020-19972-7","volume":"11","author":"S Pajovic","year":"2020","unstructured":"Pajovic S, Siddaway R, Bridge T et al (2020) Epigenetic activation of a RAS\/MYC axis in H3.3K27M-driven cancer. Nat Commun 11(1):6216","journal-title":"Nat Commun"},{"issue":"2","key":"493_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W (2015) HTSeq\u2014a Python framework to work with high-throughput sequencing data. Bioinformatics 31(2):166\u2013169","journal-title":"Bioinformatics"},{"issue":"1","key":"493_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1):139\u2013140","journal-title":"Bioinformatics"},{"issue":"43","key":"493_CR21","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545\u201315550","journal-title":"Proc Natl Acad Sci U S A"},{"key":"493_CR22","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.jconrel.2020.11.010","volume":"330","author":"J Ishida","year":"2021","unstructured":"Ishida J, Alli S, Bondoc A et al (2021) MRI-guided focused ultrasound enhances drug delivery in experimental diffuse intrinsic pontine glioma. J Control Release 330:1034\u20131045","journal-title":"J Control Release"},{"issue":"8","key":"493_CR23","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/s41591-018-0086-7","volume":"24","author":"M Vinci","year":"2018","unstructured":"Vinci M, Burford A, Molinari V et al (2018) Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells. Nat Med 24(8):1204\u20131215","journal-title":"Nat Med"},{"issue":"15","key":"493_CR24","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1093\/bioinformatics\/btx162","volume":"33","author":"A Ianevski","year":"2017","unstructured":"Ianevski A, He L, Aittokallio T et al (2017) SynergyFinder: a web application for analyzing drug combination dose-response matrix data. Bioinformatics 33(15):2413\u20132415","journal-title":"Bioinformatics"},{"issue":"15","key":"493_CR25","first-page":"5749","volume":"9","author":"MC Kutko","year":"2003","unstructured":"Kutko MC, Glick RD, Butler LM et al (2003) Histone deacetylase inhibitors induce growth suppression and cell death in human rhabdomyosarcoma in vitro. Clin Cancer Res 9(15):5749\u20135755","journal-title":"Clin Cancer Res"},{"issue":"4","key":"493_CR26","first-page":"962","volume":"7","author":"LM Butler","year":"2001","unstructured":"Butler LM, Webb Y, Agus DB et al (2001) Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase. Clin Cancer Res 7(4):962\u2013970","journal-title":"Clin Cancer Res"},{"issue":"3","key":"493_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","volume":"7","author":"D Hargrave","year":"2006","unstructured":"Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7(3):241\u2013248","journal-title":"Lancet Oncol"},{"key":"493_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.critrevonc.2017.10.013","volume":"120","author":"HS Gwak","year":"2017","unstructured":"Gwak HS, Park HJ (2017) Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG). Crit Rev Oncol Hematol 120:111\u2013119","journal-title":"Crit Rev Oncol Hematol"},{"issue":"19","key":"493_CR29","doi-asserted-by":"publisher","first-page":"7193","DOI":"10.3390\/ijms21197193","volume":"21","author":"MS Graham","year":"2020","unstructured":"Graham MS, Mellinghoff IK (2020) Histone-mutant glioma: molecular mechanisms, preclinical models, and implications for therapy. Int J Mol Sci 21(19):7193","journal-title":"Int J Mol Sci"},{"key":"493_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-981-15-8104-5_6","volume":"1283","author":"VM Lu","year":"2021","unstructured":"Lu VM, Daniels DJ (2021) Epigenetic-targeted treatments for H3K27M-mutant midline gliomas. Adv Exp Med Biol 1283:73\u201384","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"493_CR31","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nm0715-827a","volume":"21","author":"CS Grasso","year":"2015","unstructured":"Grasso CS, Tang Y, Truffaux N et al (2015) Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 21(7):827","journal-title":"Nat Med"},{"issue":"8","key":"493_CR32","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/sj.leu.2404282","volume":"20","author":"HG Einsiedel","year":"2006","unstructured":"Einsiedel HG, Kawan L, Eckert C et al (2006) Histone deacetylase inhibitors have antitumor activity in two NOD\/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia. Leukemia 20(8):1435\u20131436","journal-title":"Leukemia"},{"issue":"7","key":"493_CR33","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/ijms18071414","volume":"18","author":"T Eckschlager","year":"2017","unstructured":"Eckschlager T, Plch J, Stiborova M et al (2017) Histone deacetylase inhibitors as anticancer drugs. Int J Mol Sci 18(7):1414","journal-title":"Int J Mol Sci"},{"issue":"4","key":"493_CR34","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.cell.2008.03.025","volume":"133","author":"Y Tang","year":"2008","unstructured":"Tang Y, Zhao W, Chen Y et al (2008) Acetylation is indispensable for p53 activation. Cell 133(4):612\u2013626","journal-title":"Cell"},{"key":"493_CR35","doi-asserted-by":"publisher","first-page":"1118268","DOI":"10.3389\/fonc.2023.1118268","volume":"13","author":"K Eloranta","year":"2023","unstructured":"Eloranta K, Pihlajoki M, Liljestrom E et al (2023) SLC-0111, an inhibitor of carbonic anhydrase IX, attenuates hepatoblastoma cell viability and migration. Front Oncol 13:1118268","journal-title":"Front Oncol"},{"issue":"10","key":"493_CR36","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3390\/biology11101464","volume":"11","author":"Y Xu","year":"2022","unstructured":"Xu Y, Fan S, Liu Y et al (2022) HDAC1 in the ovarian granulosa cells of tan sheep improves cumulus cell expansion and oocyte maturation independently of the EGF-like growth factors. Biology 11(10):1464","journal-title":"Biology"},{"issue":"8","key":"493_CR37","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.3390\/ijms21082983","volume":"21","author":"V Ciccone","year":"2020","unstructured":"Ciccone V, Filippelli A, Angeli A et al (2020) Pharmacological inhibition of CA-IX impairs tumor cell proliferation, migration and invasiveness. Int J Mol Sci 21(8):2983","journal-title":"Int J Mol Sci"},{"issue":"7","key":"493_CR38","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3390\/cancers12071723","volume":"12","author":"J Haapasalo","year":"2020","unstructured":"Haapasalo J, Nordfors K, Haapasalo H et al (2020) The expression of carbonic anhydrases II, IX and XII in brain tumors. Cancers 12(7):1723","journal-title":"Cancers"},{"issue":"16","key":"493_CR39","doi-asserted-by":"publisher","first-page":"7259","DOI":"10.1158\/0008-5472.CAN-04-4480","volume":"65","author":"S Sobhanifar","year":"2005","unstructured":"Sobhanifar S, Aquino-Parsons C, Stanbridge EJ et al (2005) Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors. Cancer Res 65(16):7259\u20137266","journal-title":"Cancer Res"},{"issue":"7","key":"493_CR40","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.celrep.2017.07.049","volume":"20","author":"E Johansson","year":"2017","unstructured":"Johansson E, Grassi ES, Pantazopoulou V et al (2017) CD44 interacts with HIF-2alpha to modulate the hypoxic phenotype of perinecrotic and perivascular glioma cells. Cell Rep 20(7):1641\u20131653","journal-title":"Cell Rep"},{"issue":"2","key":"493_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00018-009-0187-z","volume":"67","author":"JY Hu","year":"2010","unstructured":"Hu JY, Chu ZG, Han J et al (2010) The p38\/MAPK pathway regulates microtubule polymerization through phosphorylation of MAP4 and Op18 in hypoxic cells. Cell Mol Life Sci 67(2):321\u2013333","journal-title":"Cell Mol Life Sci"},{"key":"493_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/978-3-030-34461-0_34","volume":"1232","author":"HJ Lee","year":"2020","unstructured":"Lee HJ, Han HJ (2020) Role of microtubule-associated factors in HIF1alpha nuclear translocation. Adv Exp Med Biol 1232:271\u2013276","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"493_CR43","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1053\/j.gastro.2019.05.004","volume":"157","author":"PC McDonald","year":"2019","unstructured":"McDonald PC, Chafe SC, Brown WS et al (2019) Regulation of pH by carbonic anhydrase 9 mediates survival of pancreatic cancer cells with activated KRAS in response to hypoxia. Gastroenterology 157(3):823\u2013837","journal-title":"Gastroenterology"},{"issue":"8","key":"493_CR44","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/bioinformatics\/btaa918","volume":"37","author":"B Shaker","year":"2021","unstructured":"Shaker B, Yu MS, Song JS et al (2021) LightBBB: computational prediction model of blood-brain-barrier penetration based on LightGBM. Bioinformatics 37(8):1135\u20131139","journal-title":"Bioinformatics"},{"key":"493_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jconrel.2018.05.005","volume":"281","author":"S Alli","year":"2018","unstructured":"Alli S, Figueiredo CA, Golbourn B et al (2018) Brainstem blood brain barrier disruption using focused ultrasound: a demonstration of feasibility and enhanced doxorubicin delivery. J Control Release 281:29\u201341","journal-title":"J Control Release"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-024-00493-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10014-024-00493-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-024-00493-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T07:17:51Z","timestamp":1729754271000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10014-024-00493-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":45,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["493"],"URL":"https:\/\/doi.org\/10.1007\/s10014-024-00493-w","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,24]]},"assertion":[{"value":"6 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Research Ethics Board of the Hospital for Sick Children (Toronto, ON, REB approval number 0020020238), where patients who provided tumor tissue material provided written informed consent prior to sample acquisition.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent to publish"}},{"value":"The authors have no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}